Genome Editing in hPSCs Reveals GATA6 Haploinsufficiency and a Genetic Interaction with GATA4 in Human Pancreatic Development

Zhong Dong Shi; Kihyun Lee; Dapeng Yang; Sadaf Amin; Nipun Verma; Qing V. Li; Zengrong Zhu; Chew Li Soh; Ritu Kumar; Todd Evans; Shuibing Chen; Danwei Huangfu

doi:10.1016/j.stem.2017.01.001

Genome Editing in hPSCs Reveals GATA6 Haploinsufficiency and a Genetic Interaction with GATA4 in Human Pancreatic Development

Zhong Dong Shi, Kihyun Lee, Dapeng Yang, Sadaf Amin, Nipun Verma, Qing V. Li, Zengrong Zhu, Chew Li Soh, Ritu Kumar, Todd Evans, Shuibing Chen, Danwei Huangfu

Pharmaceutical Sciences

Research output: Contribution to journal › Article › peer-review

106 Scopus citations

Abstract

Human disease phenotypes associated with haploinsufficient gene requirements are often not recapitulated well in animal models. Here, we have investigated the association between human GATA6 haploinsufficiency and a wide range of clinical phenotypes that include neonatal and adult-onset diabetes using CRISPR (clustered regularly interspaced short palindromic repeat)/Cas9-mediated genome editing coupled with human pluripotent stem cell (hPSC) directed differentiation. We found that loss of one GATA6 allele specifically affects the differentiation of human pancreatic progenitors from the early PDX1+ stage to the more mature PDX1+NKX6.1+ stage, leading to impaired formation of glucose-responsive β-like cells. In addition to this GATA6 haploinsufficiency, we also identified dosage-sensitive requirements for GATA6 and GATA4 in the formation of both definitive endoderm and pancreatic progenitor cells. Our work expands the application of hPSCs from studying the impact of individual gene loci to investigation of multigenic human traits, and it establishes an approach for identifying genetic modifiers of human disease.

Original language	English
Pages (from-to)	675-688.e6
Journal	Cell Stem Cell
Volume	20
Issue number	5
DOIs	https://doi.org/10.1016/j.stem.2017.01.001
State	Published - 4 May 2017

Bibliographical note

Funding Information:
We thank Drs. Licia Selleri and Wenjun Guo and members of the D.H. laboratory for insightful discussions and critical reading of the manuscript. The mouse anti-NKX6.1 and rat anti-C-Peptide antibodies were obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242, USA. This study was funded in part by the New York State Stem Cell Science Program (NYSTEM) (C029567 and C029156), the NIH/NIDDK (R01DK096239, DP3DK111907 and DP2DK098093-01), the Tri-Institutional Stem Cell Initiative (#2016-004), and a MSKCC Cancer Center Support grant (P30 CA008748). K.L. was supported by the Korean Government Scholarship Program for Study Overseas and Mogam Science Scholarship Foundation. N.V. was supported by the Howard Hughes Medical Institute (HHMI) Medical Research Fellowship. Z.Z. was supported by a NYSTEM postdoctoral fellowship (C026879) from the Center for Stem Cell Biology of the Sloan Kettering Institute.

Publisher Copyright:
© 2017 Elsevier Inc.

Keywords

CRISPR/Cas9 genome editing
GATA6 and GATA4
definitive endoderm
genetic modifier
haploinsufficiency
human embryonic stem cells
human pluripotent stem cells disease modeling
insulin producing pancreatic beta cells
pancreatic agenesis and neonatal diabetes
pancreatic progenitor

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.stem.2017.01.001

Cite this

@article{3e986c36e1794e3a9ba6606b94fb3406,

title = "Genome Editing in hPSCs Reveals GATA6 Haploinsufficiency and a Genetic Interaction with GATA4 in Human Pancreatic Development",

abstract = "Human disease phenotypes associated with haploinsufficient gene requirements are often not recapitulated well in animal models. Here, we have investigated the association between human GATA6 haploinsufficiency and a wide range of clinical phenotypes that include neonatal and adult-onset diabetes using CRISPR (clustered regularly interspaced short palindromic repeat)/Cas9-mediated genome editing coupled with human pluripotent stem cell (hPSC) directed differentiation. We found that loss of one GATA6 allele specifically affects the differentiation of human pancreatic progenitors from the early PDX1+ stage to the more mature PDX1+NKX6.1+ stage, leading to impaired formation of glucose-responsive β-like cells. In addition to this GATA6 haploinsufficiency, we also identified dosage-sensitive requirements for GATA6 and GATA4 in the formation of both definitive endoderm and pancreatic progenitor cells. Our work expands the application of hPSCs from studying the impact of individual gene loci to investigation of multigenic human traits, and it establishes an approach for identifying genetic modifiers of human disease.",

keywords = "CRISPR/Cas9 genome editing, GATA6 and GATA4, definitive endoderm, genetic modifier, haploinsufficiency, human embryonic stem cells, human pluripotent stem cells disease modeling, insulin producing pancreatic beta cells, pancreatic agenesis and neonatal diabetes, pancreatic progenitor",

author = "Shi, {Zhong Dong} and Kihyun Lee and Dapeng Yang and Sadaf Amin and Nipun Verma and Li, {Qing V.} and Zengrong Zhu and Soh, {Chew Li} and Ritu Kumar and Todd Evans and Shuibing Chen and Danwei Huangfu",

note = "Funding Information: We thank Drs. Licia Selleri and Wenjun Guo and members of the D.H. laboratory for insightful discussions and critical reading of the manuscript. The mouse anti-NKX6.1 and rat anti-C-Peptide antibodies were obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242, USA. This study was funded in part by the New York State Stem Cell Science Program (NYSTEM) (C029567 and C029156), the NIH/NIDDK (R01DK096239, DP3DK111907 and DP2DK098093-01), the Tri-Institutional Stem Cell Initiative (#2016-004), and a MSKCC Cancer Center Support grant (P30 CA008748). K.L. was supported by the Korean Government Scholarship Program for Study Overseas and Mogam Science Scholarship Foundation. N.V. was supported by the Howard Hughes Medical Institute (HHMI) Medical Research Fellowship. Z.Z. was supported by a NYSTEM postdoctoral fellowship (C026879) from the Center for Stem Cell Biology of the Sloan Kettering Institute. Publisher Copyright: {\textcopyright} 2017 Elsevier Inc.",

year = "2017",

month = may,

day = "4",

doi = "10.1016/j.stem.2017.01.001",

language = "English",

volume = "20",

pages = "675--688.e6",

journal = "Cell Stem Cell",

issn = "1934-5909",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - Genome Editing in hPSCs Reveals GATA6 Haploinsufficiency and a Genetic Interaction with GATA4 in Human Pancreatic Development

AU - Shi, Zhong Dong

AU - Lee, Kihyun

AU - Yang, Dapeng

AU - Amin, Sadaf

AU - Verma, Nipun

AU - Li, Qing V.

AU - Zhu, Zengrong

AU - Soh, Chew Li

AU - Kumar, Ritu

AU - Evans, Todd

AU - Chen, Shuibing

AU - Huangfu, Danwei

N1 - Funding Information: We thank Drs. Licia Selleri and Wenjun Guo and members of the D.H. laboratory for insightful discussions and critical reading of the manuscript. The mouse anti-NKX6.1 and rat anti-C-Peptide antibodies were obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242, USA. This study was funded in part by the New York State Stem Cell Science Program (NYSTEM) (C029567 and C029156), the NIH/NIDDK (R01DK096239, DP3DK111907 and DP2DK098093-01), the Tri-Institutional Stem Cell Initiative (#2016-004), and a MSKCC Cancer Center Support grant (P30 CA008748). K.L. was supported by the Korean Government Scholarship Program for Study Overseas and Mogam Science Scholarship Foundation. N.V. was supported by the Howard Hughes Medical Institute (HHMI) Medical Research Fellowship. Z.Z. was supported by a NYSTEM postdoctoral fellowship (C026879) from the Center for Stem Cell Biology of the Sloan Kettering Institute. Publisher Copyright: © 2017 Elsevier Inc.

PY - 2017/5/4

Y1 - 2017/5/4

N2 - Human disease phenotypes associated with haploinsufficient gene requirements are often not recapitulated well in animal models. Here, we have investigated the association between human GATA6 haploinsufficiency and a wide range of clinical phenotypes that include neonatal and adult-onset diabetes using CRISPR (clustered regularly interspaced short palindromic repeat)/Cas9-mediated genome editing coupled with human pluripotent stem cell (hPSC) directed differentiation. We found that loss of one GATA6 allele specifically affects the differentiation of human pancreatic progenitors from the early PDX1+ stage to the more mature PDX1+NKX6.1+ stage, leading to impaired formation of glucose-responsive β-like cells. In addition to this GATA6 haploinsufficiency, we also identified dosage-sensitive requirements for GATA6 and GATA4 in the formation of both definitive endoderm and pancreatic progenitor cells. Our work expands the application of hPSCs from studying the impact of individual gene loci to investigation of multigenic human traits, and it establishes an approach for identifying genetic modifiers of human disease.

AB - Human disease phenotypes associated with haploinsufficient gene requirements are often not recapitulated well in animal models. Here, we have investigated the association between human GATA6 haploinsufficiency and a wide range of clinical phenotypes that include neonatal and adult-onset diabetes using CRISPR (clustered regularly interspaced short palindromic repeat)/Cas9-mediated genome editing coupled with human pluripotent stem cell (hPSC) directed differentiation. We found that loss of one GATA6 allele specifically affects the differentiation of human pancreatic progenitors from the early PDX1+ stage to the more mature PDX1+NKX6.1+ stage, leading to impaired formation of glucose-responsive β-like cells. In addition to this GATA6 haploinsufficiency, we also identified dosage-sensitive requirements for GATA6 and GATA4 in the formation of both definitive endoderm and pancreatic progenitor cells. Our work expands the application of hPSCs from studying the impact of individual gene loci to investigation of multigenic human traits, and it establishes an approach for identifying genetic modifiers of human disease.

KW - CRISPR/Cas9 genome editing

KW - GATA6 and GATA4

KW - definitive endoderm

KW - genetic modifier

KW - haploinsufficiency

KW - human embryonic stem cells

KW - human pluripotent stem cells disease modeling

KW - insulin producing pancreatic beta cells

KW - pancreatic agenesis and neonatal diabetes

KW - pancreatic progenitor

UR - http://www.scopus.com/inward/record.url?scp=85012873249&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2017.01.001

DO - 10.1016/j.stem.2017.01.001

M3 - Article

C2 - 28196600

AN - SCOPUS:85012873249

SN - 1934-5909

VL - 20

SP - 675-688.e6

JO - Cell Stem Cell

JF - Cell Stem Cell

IS - 5

ER -

Genome Editing in hPSCs Reveals GATA6 Haploinsufficiency and a Genetic Interaction with GATA4 in Human Pancreatic Development

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this